Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Gross PP&E Adjustments: 2011-2021

Historic Other Gross PP&E Adjustments for Neurocrine Biosciences (NBIX) over the last 3 years, with Sep 2021 value amounting to -$97.9 million.

  • Neurocrine Biosciences' Other Gross PP&E Adjustments fell 37.89% to -$97.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$291.7 million, marking a year-over-year decrease of 35.55%. This contributed to the annual value of $3.5 million for FY2020, which is 191.67% up from last year.
  • As of Q3 2021, Neurocrine Biosciences' Other Gross PP&E Adjustments stood at -$97.9 million, which was up 2.39% from -$100.3 million recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Other Gross PP&E Adjustments high stood at $62.1 million for Q4 2018, and its period low was -$100.3 million during Q2 2021.
  • In the last 3 years, Neurocrine Biosciences' Other Gross PP&E Adjustments had a median value of -$71.0 million in 2020 and averaged -$60.7 million.
  • As far as peak fluctuations go, Neurocrine Biosciences' Other Gross PP&E Adjustments plummeted by 98.07% in 2019, and later spiked by 191.67% in 2020.
  • Quarterly analysis of 5 years shows Neurocrine Biosciences' Other Gross PP&E Adjustments stood at $38.4 million in 2017, then soared by 61.86% to $62.1 million in 2018, then plummeted by 98.07% to $1.2 million in 2019, then skyrocketed by 191.67% to $3.5 million in 2020, then crashed by 37.89% to -$97.9 million in 2021.
  • Its last three reported values are -$97.9 million in Q3 2021, -$100.3 million for Q2 2021, and -$97.0 million during Q1 2021.